Quantcast

Latest FDA Stories

2014-07-09 23:05:52

A top national clinic for men’s sexual health, NuMale Medical Center today announced that its fifth facility is now open in Omaha, Nebraska. Led by Chief Medical Officer Dr. Christopher Asandra, NuMale offers a vast array of the most state-of-the art, FDA-approved, customized treatments for erectile dysfunction, low testosterone and other issues associated with men’s health. Omaha, NE (PRWEB) July 09, 2014 NuMale Medical Center, a leading provider of sexual dysfunction treatments,...

2014-07-09 23:02:41

The Firm is evaluating hysterectomy cancer lawsuits on behalf of women who experienced the spread of uterine sarcoma and other cancers, allegedly due to the use of power morcellators in laparoscopic hysterectomies and fibroid removals. New York, New York (PRWEB) July 09, 2014 As the Firm continues to evaluate morcellator lawsuits (http://www.gynecaremorcellatorlawsuit.com/) on behalf of women who allegedly experienced the spread of uterine cancers due to the use of power morcellators in...

2014-07-09 12:31:16

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Antifungal Drugs : Technologies and Global Marketshttps://www.reportbuyer.com/product/2212016/Antifungal-Drugs--Technologies-and-Global-Markets.htmlThis report aims to determine the current status of the global human antifungal market and assess its growth potential over the five-year period from 2013 through 2018. It covers approved human therapeutics along with focusing on therapeutics in...

2014-07-08 23:14:36

On July 2, the FDA announced that Medtronic Duet External Drainage and Monitoring System is recalled (Class I). In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 08, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Medtronic Duet External Drainage and Monitoring System. The FDA informed on July 2,...

2014-07-08 23:05:03

Have you experienced intestinal problems after taking Benicar, Azor or Tribenzor? There are current lawsuits being filed on behalf of victims. Toledo, OH (PRWEB) July 08, 2014 The U.S. Food and Drug Administration (FDA) issued a warning on July 3, 2013, that the blood pressure drug, olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause serious intestinal problems known as sprue-like enteropathy. The FDA also required changes to the labels of...

2014-07-08 23:03:02

PharmacyChecker.com published almost 2000 consumer comments showing that Americans are concerned about new federal regulations expanding the authority of the FDA to destroy safe drug imports for personal use. PharmacyChecker.com submitted public comments to the FDA, offering suggestions that would protect access by Americans to safe and affordable prescription drugs. White Plains, NY (PRWEB) July 08, 2014 PharmacyChecker.com announced the publication on its website of almost 2000 comments...

2014-07-08 12:28:45

CHARLOTTE, N.C., July 8, 2014 /PRNewswire/ -- UniStrip Technologies, LLC of Charlotte NC has filed an antitrust lawsuit in the Los Angeles federal court against LifeScan, Inc., a Johnson & Johnson Company, for violations of the Sherman and Clayton Acts. In November, 2013 the FDA cleared UniStrip to market test strips that are compatible with four of LifeScan's OneTouch Ultra blood glucose meters. The key to UniStrip's success would be its highly accurate strips, as cleared by...

2014-07-08 12:28:38

MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. Every year influenza vaccine manufacturers must receive approval from the Agency for changes they make to the upcoming season's manufacturing process and product formulation, as the influenza vaccine is adapted annually. Early approval for Flublok will enable delivery on time to...

2014-07-08 08:31:22

- Toujeo dossier already accepted by EMA - PARIS, July 8, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), an investigational basal insulin. The acceptance of the NDA follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for...

2014-07-08 08:31:18

Anticipated FDA action set for October 2014 STAMFORD, Conn., July 8, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) has granted Priority Review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet (HYD). This investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate for the purpose of misuse or abuse by...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related